AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2020
Sep 11, 2020
31676_dirs_2020-09-10_5951e4f4-b44c-4553-9d41-6b89ee478888.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2020-09-08
Reporting Person: Lalwani Nikhil (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-09-08 | Common Stock | A | 28508 | — | Acquired | 28508 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-09-08 | Stock Option (right to buy) | $29 | A | 179643 | Acquired | 2030-09-08 | Common Stock (179643) | Direct |
Footnotes
F1: Represents a restricted stock award that will vest as to 25% of the total shares on each of September 8, 2021, September 8, 2022, September 8, 2023 and September 8, 2024.
F2: The option will vest and become exercisable as to 25% of the total shares on each of September 8, 2021, September 8, 2022, September 8, 2023 and September 8, 2024.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3